Meningococcal vaccine refers to any vaccine used to prevent infection by Neisseria meningitidis. Different versions are effective against some or all...
50 KB (4,301 words) - 21:56, 23 September 2024
countries. During epidemics the incidence of meningococcal disease approaches 100 per 100,000. Meningococcal vaccines have sharply reduced the incidence of the...
45 KB (4,915 words) - 16:51, 26 September 2024
Neisseria meningitidis (redirect from Meningococcal)
The multiple subtypes have hindered development of a universal vaccine for meningococcal disease.[citation needed] Lipooligosaccharide (LOS) is a component...
41 KB (4,640 words) - 09:51, 25 May 2024
NmVac4-A/C/Y/W-135 (category Meningococcal vaccines)
name of the polysaccharide vaccine against the bacterium (specifically serogroups A, C, Y, and W-135) that causes meningococcal meningitis. The product,...
24 KB (2,601 words) - 03:15, 15 December 2023
Oral Cholera Vaccine". indiainfoline.com. Retrieved 28 December 2016. "Hilleman labs develops low-cost meningococcal conjugate vaccine". indiainfoline...
8 KB (629 words) - 13:36, 12 August 2024
meningococcal disease caused by serogroup A strains. By the mid-1990s, three vaccine manufacturers were developing meningococcal conjugate vaccines against...
32 KB (3,513 words) - 09:58, 7 August 2024
cross-protection by meningococcal vaccines is plausible. A study published in 2017 showed that MeNZB group B meningococcal vaccine provided a partial protection...
56 KB (5,661 words) - 07:45, 16 August 2024
MeNZB (category Meningococcal vaccines)
MeNZB was a vaccine against a specific strain of group B meningococcus, used to control an epidemic of meningococcal disease in New Zealand. Most people...
9 KB (1,009 words) - 07:15, 2 September 2023
Penbraya (category Meningococcal vaccines)
conjugate vaccine developed by Pfizer for the prevention of invasive meningococcal disease in people 10 through 25 years of age. Invasive meningococcal disease...
8 KB (587 words) - 06:59, 24 September 2024
possible. Both a serogroup A, C, W, Y conjugate meningococcal vaccine and a serogroup B meningococcal vaccine are recommended for people receiving eculizumab...
44 KB (3,805 words) - 00:43, 23 July 2024